Insider trading

Period: 120 months Stock: VRTX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

737 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

737 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

737 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

737 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
737 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
737 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

737 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
7 May 2020
LEIDEN JEFFREY M Executive Chairman
Sold, plan not stated 6×
$25.46M 94,369 at 269.78
69.8%
Sold half or more
7 May 2020
SACHS BRUCE I Director
Sold, plan not stated 6×
$12.14M 45,000 at 269.80
80.1%
Sold half or more
6 May 2020
Kewalramani Reshma CEO & President
Sold, plan not stated 5×
$565.88K 2,074 at 272.85
7.2%
6 May 2020
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 4×
$333.20K 1,222 at 272.66
4.1%
6 May 2020
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 5×
$333.16K 1,222 at 272.64
4.4%
6 May 2020
Silva Paul M SVP & Controller
Sold, plan not stated 6×
$293.47K 1,076 at 272.74
6.7%
6 May 2020
Tatsis Ourania EVP, Chief Regulatory Officer
Sold, plan not stated 6×
$263.43K 966 at 272.70
7.0%
6 May 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated
$184.16K 669 at 275.28
1.9%
5 May 2020
LEIDEN JEFFREY M Executive Chairman
Sold, plan not stated 9×
$25.48M 94,372 at 269.94
66.9%
Sold half or more
5 May 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated 7×
$3.61M 13,356 at 270.01
27.6%
4 May 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated 7×
$11.48M 43,752 at 262.28
55.5%
Sold half or more
4 May 2020
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 5×
$607.83K 2,330 at 260.87
8.0%
4 May 2020
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 5×
$607.80K 2,330 at 260.86
7.5%
4 May 2020
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 5×
$404.96K 1,553 at 260.76
4.2%
4 May 2020
Silva Paul M SVP & Controller
Sold, plan not stated 5×
$211.05K 809 at 260.87
5.1%
29 Apr 2020
Parini Michael EVP, Chief Adm, Leg & BD Off
Sold, plan not stated 6×
$541.77K 2,125 at 254.95
7.3%
28 Apr 2020
Lee Yuchun Director
Sold, plan not stated 7×
$290.12K 1,125 at 257.88
37.5%
27 Apr 2020
Lee Yuchun Director
Sold, plan not stated 5×
$542.42K 2,000 at 271.21
51.6%
Sold half or more
24 Apr 2020
Lee Yuchun Director
Sold, plan not stated 4×
$536.29K 2,000 at 268.14
51.6%
Sold half or more
23 Apr 2020
Lee Yuchun Director
Sold, plan not stated 7×
$545.05K 2,000 at 272.53
51.6%
Sold half or more
22 Apr 2020
Lee Yuchun Director
Sold, plan not stated 6×
$535.75K 2,000 at 267.88
51.6%
Sold half or more
21 Apr 2020
Lee Yuchun Director
Sold, plan not stated 7×
$533.52K 2,000 at 266.76
51.6%
Sold half or more
20 Apr 2020
Lee Yuchun Director
Sold, plan not stated 4×
$546.31K 2,000 at 273.16
51.6%
Sold half or more
13 Apr 2020
Silva Paul M SVP & Controller
Sold, plan not stated 6×
$213.65K 859 at 248.72
5.4%
6 Apr 2020
Silva Paul M SVP & Controller
Sold, plan not stated
$1.25M 4,891 at 255.57
24.7%
25 Feb 2020
LEIDEN JEFFREY M CEO & President
Sold, plan not stated 8×
$2.46M 10,550 at 233.46
10.2%
25 Feb 2020
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 8×
$849.42K 3,634 at 233.74
9.4%
25 Feb 2020
Kewalramani Reshma EVP and CMO
Sold, plan not stated 8×
$848.37K 3,634 at 233.45
12.0%
25 Feb 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated 8×
$788.40K 3,376 at 233.53
9.3%
25 Feb 2020
Parini Michael EVP, CL&AO
Sold, plan not stated 6×
$707.01K 3,028 at 233.49
10.1%
25 Feb 2020
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 7×
$706.78K 3,028 at 233.41
9.5%
25 Feb 2020
Tatsis Ourania SVP, CRO
Sold, plan not stated 6×
$302.19K 1,296 at 233.17
9.2%
25 Feb 2020
Silva Paul M SVP & Controller
Sold, plan not stated 7×
$252.13K 1,080 at 233.45
6.7%
18 Feb 2020
LEIDEN JEFFREY M CEO & President
Sold, plan not stated 5×
$2.85M 11,685 at 243.52
9.5%
18 Feb 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated 5×
$849.78K 3,489 at 243.56
8.1%
18 Feb 2020
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 5×
$762.20K 3,128 at 243.67
8.3%
18 Feb 2020
Parini Michael EVP, CL&AO
Sold, plan not stated 5×
$762.02K 3,128 at 243.61
8.8%
18 Feb 2020
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 5×
$761.84K 3,128 at 243.56
7.0%
18 Feb 2020
Silva Paul M SVP & Controller
Sold, plan not stated 5×
$380.96K 1,564 at 243.58
8.5%
18 Feb 2020
Tatsis Ourania SVP, CRO
Sold, plan not stated 5×
$311.58K 1,279 at 243.62
7.8%
18 Feb 2020
Kewalramani Reshma EVP and CMO
Sold, plan not stated 5×
$288.07K 1,183 at 243.51
3.4%
11 Feb 2020
LEIDEN JEFFREY M CEO & President
Sold, plan not stated 6×
$11.69M 47,523 at 246.09
26.4%
11 Feb 2020
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 6×
$4.19M 17,032 at 246.11
29.9%
11 Feb 2020
Parini Michael EVP, CL&AO
Sold, plan not stated 6×
$4.15M 16,882 at 246.11
30.8%
11 Feb 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated 6×
$3.22M 13,070 at 246.08
22.1%
11 Feb 2020
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 6×
$2.78M 11,286 at 246.09
19.3%
11 Feb 2020
Silva Paul M SVP & Controller
Sold, plan not stated 5×
$1.44M 5,862 at 246.04
22.9%
10 Feb 2020
Lee Yuchun Director
Sold, plan not stated 5×
$286.40K 1,181 at 242.51
38.6%
7 Feb 2020
Lee Yuchun Director
Sold, plan not stated 5×
$475.64K 2,000 at 237.82
51.6%
Sold half or more
6 Feb 2020
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 5×
$667.25K 2,787 at 239.42
4.0%
Showing 351–400 of 737. ← Newer Page 8 of 15 Older →